Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery

British Journal of Anaesthesia

Volumn 112, Issue 2, 2014, Pages 255-264

  Skhirtladze, K ^a   Base, E M ^a   Lassnigg, A ^a   Kaider, A ^a   Linke, S ^a   Dworschak, M ^a   Hiesmayr, M J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

blood loss; coagulation; colloids; fluid regime; Ringer's lactate; rotation thromboelastometry; transfusion

Indexed keywords

CREATININE; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; HETASTARCH; HUMAN SERUM ALBUMIN; RINGER LACTATE SOLUTION;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIAC PATIENT; CHEST TUBE; COLLOID; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYSTALLOID; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FLUID BALANCE; FLUID THERAPY; HEART SURGERY; HEMODILUTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; THORAX DRAINAGE; THROMBOCYTE TRANSFUSION; VERY ELDERLY; YOUNG ADULT;

BLOOD LOSS; COAGULATION; COLLOIDS; FLUID REGIME; RINGER'S LACTATE; ROTATION THROMBOELASTOMETRY; TRANSFUSION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FEMALE; FLUID THERAPY; HEMODILUTION; HEMOSTASIS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; LENGTH OF STAY; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POSTOPERATIVE HEMORRHAGE; SURGICAL PROCEDURES, ELECTIVE; YOUNG ADULT;

EID: 84892738297     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet348     Document Type: Article

References (47)

1. Holte K, Kehlet H. Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg 2006; 202: 971-89
2. Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108: 1741-6
3. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 2004; 18: 429-37
4. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997; 78: 974-83
5. de Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of vonWillebrand factorafter intravenous administrationofarapidlydegradablehydroxyethyl starch(HES200/0. 5/6) in healthy human subjects. Intensive Care Med 2001; 27: 1825-9
6. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2
7. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; 1: CD007594
8. Schortgen F, Girou E, Deye N, Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34: 2157-68
9. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic reviewand meta-analysis. J AmMed Assoc 2013; 309: 678-88
10. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/ 0. 42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-34
11. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11
12. Jungheinrich C, SauermannW, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0. 4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 2004; 5: 1-9
13. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Anesth Analg 2000; 90: 274-9
14. Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92: 1402-7
15. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-60
16. Navickis RJ, Haynes GR,Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144: 223-30
17. Palanzo DA, Zarro DL, Manley NJ, Montesano RM, Quinn M, Gustafson PA. Effect of surface coating on platelet count drop during cardiopulmonary bypass. Perfusion 1999; 14: 195-200
18. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G,Wadenvik H. The effect of albumin priming solution on platelet activation during experimental long-term perfusion. Perfusion 1998; 13: 187-91
19. DiNardo J. Physiology and techniques of extracorporeal circulation in the pediatric patient. Pediatric Cardiac Anesthesia, 4th Edn. Lippincott Williams & Wilkins, 2005; 228-52
20. Ohqvist G, Settergren G, Bergstrom K, Lundberg S. Plasma colloid osmotic pressure during open-heart surgery using non-colloid or colloid priming solution in the extracorporeal circuit. Scand J Thorac Cardiovasc Surg 1981; 15: 251-5
21. SadeRM,StroudMR, CrawfordFAJr, Kratz JM, DearingJP, BartlesDM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89: 713-22
22. Theusinger OM, Nurnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg 2010; 37: 677-83
23. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-95
24. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10
25. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82
26. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83: S27-86
27. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008; 36: 1129-37
28. HimpeD. Colloids versus crystalloids as priming solutions forcardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg 2003; 54: 207-15
29. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-33
30. SedrakyanA,GondekK, Paltiel D, Elefteriades JA. Volumeexpansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003; 123: 1853-7
31. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90: 801-7
32. Hanart C, Khalife M, De Ville A, Otte F, De Hert S, Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0. 4. Crit Care Med 2009; 37: 696-701
33. Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0. 4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0. 5 at recommended doses. Anesthesiology 2003; 99: 42-7
34. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009; 108: 30-6
35. Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL. Effect of hydroxyethyl starch 130/0. 4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011; 75: 2397-402
36. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg 2008; 3: 45
37. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010; 104: 691-7
38. ChoiYS, ShimJK,HongSW,KimJC,KwakYL. Comparingthe effects of 5%albuminand6%hydroxyethyl starch130/0. 4oncoagulationand inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol 2010; 76: 584-91
39. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0. 4 and hydroxyethyl starch 200/0. 5 using thrombelastography. Anesth Analg 1998; 87: 989-93
40. Schols SE, Lance MD, Feijge MA, et al. Impaired thrombingeneration and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010; 103: 318-28
41. Velik-Salchner C, Maier S, Innerhofer P, et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg 2009; 108: 1747-54
42. Stogermuller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91: 823-7
43. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56
44. Bayer O, Reinhart K, Kohl M, et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012; 40: 2543-51
45. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39
46. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005; 152: 3-12
47. Base EM, Standl T, Lassnigg A, et al. Efficacy and safety of hydroxyethyl starch 6% 130/0. 4 in a balanced electrolyte solution (Volulyte) during cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25: 407-14